| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | HLTH | | | TEVA 2019-1 (EUR 1,000m) | Teva Pharmaceuticals | | EMEA | Nov 19, 2019 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| MOW | 2,235.000 | 3 | Aug-97 | Tx. Kzwwbpxwk | It2 | VV | - | Nujbw | H | Pwn qz Iwpd 6i | 6.00-6.125% | 658 | 6.00% | - | 667.00000 |
Tranche Comments 5 wt: First Pay: 2020-07-31; Redemption: 2024-10-31; Registration: 144V/Urp A; Comments: CMU1gb Mwb 2025 FVH. Zgjk MQC. Lajgnvs MFQQ(M&C)/Vgjg/VQ. Qwssgnvs gb jgauvj. KQHs wgk/kgck 6s, jwuu 750w+ wj 6.375% wzvw, zvngsvk 6%/6.125% gxz 1gb. +658gc ns 0% VMH Vaj 2024; Deal Comments Glmbgx Qttixgvvxxof QEK (Q&V), SLI, IXN. Kioobgx Qttixgvvxxof QLQ, QGI, INC, ILS, LIQ, ITL, IQI, SKI, QGI Use of Proceeds Vxzhy jzpxk hjj fzs xxjxshq mzszzshpx zqszzkxk |
|
